ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL IN SURGERY FOR COLORECTAL CANCER - 8-YEAR PROGRESS REPORT

被引:46
|
作者
ROUSSELOT, LM
CONTE, AJ
COLE, DR
PASTERNACK, BS
GONZALEZ, EM
GROSSI, CE
机构
关键词
D O I
10.1007/BF02589856
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:169 / +
页数:1
相关论文
共 50 条
  • [31] 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer
    Di Paolo, Antonello
    Lencioni, Monica
    Amatori, Feclerica
    Di Donato, Samantha
    Bocci, Guido
    Orlandini, Cinzia
    Lastella, Marianna
    Federici, Francesca
    Iannopollo, Mauro
    Falcone, Alfredo
    Ricci, Sergio
    Del Tacca, Mario
    Danesil, Romano
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2749 - 2755
  • [32] 5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer
    Jover, Rodrigo
    Thuy-Phuong Nguyen
    Perez-Carbonell, Lucia
    Zapater, Pedro
    Paya, Artemio
    Alenda, Cristina
    Rojas, Estefania
    Cubiella, Joaquin
    Balaguer, Francesc
    Morillas, Juan D.
    Clofent, Juan
    Bujanda, Luis
    Rene, Josep M.
    Bessa, Xavier
    Xicola, Rosa M.
    Nicolas-Perez, David
    Castells, Antoni
    Andreu, Montserrat
    Llor, Xavier
    Boland, C. Richard
    Goel, Ajay
    GASTROENTEROLOGY, 2011, 140 (04) : 1174 - 1181
  • [33] 5-Fluorouracil exposure in adjuvant chemotherapy regimens is significantly related to disease free survival in colorectal cancer patients
    Di Paolo, Antonello
    Lencioni, Monica
    Amatori, Federica
    Di Donato, Samantha
    Federici, Francesca
    Bocci, Guido
    Falcone, Alfredo
    Ricci, Sergio
    Del Tacca, Mario
    Danesi, Romano
    CANCER RESEARCH, 2006, 66 (08)
  • [34] On 5-fluorouracil therapy of colorectal cancer
    Jensen, Soren Astrup
    DANISH MEDICAL JOURNAL, 2013, 60 (07):
  • [35] ADJUVANT PORTAL LIVER INFUSION WITH 5-FLUOROURACIL AND MITOMYCIN IN COLORECTAL-CANCER
    WEBER, W
    LAFFER, U
    METZGER, U
    ANTICANCER RESEARCH, 1993, 13 (5C) : 1839 - 1840
  • [36] Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
    M Gusella
    A C Frigo
    C Bolzonella
    R Marinelli
    C Barile
    A Bononi
    G Crepaldi
    D Menon
    L Stievano
    S Toso
    F Pasini
    E Ferrazzi
    R Padrini
    British Journal of Cancer, 2009, 100 : 1549 - 1557
  • [37] Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
    Gusella, M.
    Frigo, A. C.
    Bolzonella, C.
    Marinelli, R.
    Barile, C.
    Bononi, A.
    Crepaldi, G.
    Menon, D.
    Stievano, L.
    Toso, S.
    Pasini, F.
    Ferrazzi, E.
    Padrini, R.
    BRITISH JOURNAL OF CANCER, 2009, 100 (10) : 1549 - 1557
  • [38] Adjuvant oral 5-fluorouracil for cervical cancer
    Yamamoto, Kaichiro
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S47 - S47
  • [39] Prognostic Significance of Interaction Between Somatic APC Mutations and 5-Fluorouracil Adjuvant Chemotherapy in Taiwanese Colorectal Cancer Subjects
    Chen, Shee-Ping
    Wu, Chang-Chieh
    Lin, Shinn-Zong
    Kang, Jung-Cheng
    Su, Chin-Cheng
    Chen, Yi-Lin
    Lin, Po-Cheng
    Chiu, Sheng-Chun
    Pang, Cheng-Yoong
    Harn, Horng-Jyh
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (02): : 122 - 126
  • [40] Impact of 5-fluorouracil metabolizing enzymes on chemotherapy in patients with resectable colorectal cancer
    Ochiai, Takumi
    Umeki, Masahiko
    Miyake, Hiroshi
    Iida, Tatsumi
    Okumura, Minoru
    Ohno, Kazuhide
    Sakamoto, Masashi
    Miyoshi, Nobukazu
    Takahashi, Masahiko
    Tsumura, Hldenori
    Tokunaga, Yukihiko
    Naitou, Haruhiko
    Fukui, Takuji
    ONCOLOGY REPORTS, 2014, 32 (03) : 887 - 892